Full Description
Pharmaceutical and medical device manufacturers face relentless and costly waves of product liability claims across U.S. federal and state courts, spanning individual suits, consolidated multidistrict litigation and coordinated proceedings, multi-plaintiff actions, and class actions. As this complex area of litigation continues to expand-often into more treacherous and plaintiff-friendly venues-the stakes for getting strategy right, early and often, have never been higher.
The third edition of Drug and Device Product Liability Litigation Strategy equips litigators with clear, practical guidance from pre-litigation investigations through trial. Reflecting significant developments since the prior edition, it distills the current and evolving legal landscape impacting drug and device lawyers, and offers actionable analysis on the issues that are most likely to influence outcomes: pre-litigation investigation and risk assessment, document preservation and fact discovery, coordination in MDLs and state proceedings, class action challenges, developments in preemption and personal jurisdiction case law, admissibility of expert testimony, dispositive and pre-trial motion practice, jury selection, and trial strategy.
This edition highlights strategic inflection points and delivers practice-oriented insights to streamline case management and sharpen advocacy. With its emphasis on strategy and results, it is an indispensable resource for lawyers navigating high-profile drug and device litigation in a continually shifting environment.
Contents
1: Introduction 2: FDA's Regulation of Prescription Drugs and Devices 3: Pre-Litigation Counseling 4: Legal Issues and Theories 5: Aggregated Proceedings-Consolidation and Mass Joinder 6: Aggregated Proceedings-Class Actions 7: Aggregated Proceedings-Multidistrict Litigation 8: Fact Discovery 9: Expert Retention and Discovery 10: Expert Testimony, Rule 702, and Daubert 11: Preemption 12: The Learned Intermediary Doctrine 13: Motions in Limine 14: Jury Selection 15: The Trial of a Drug or Device Case



